← Leaderboards
Derek R Smith
Brigham And Women'S Hospital
$535,680
Attributed
$535,680
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$535,680 · 1
By mechanism
K23$535,680 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Vijay K Kuchroo$71,617,613
- Joshua A Boyce$54,050,346
- Howard L Weiner$38,267,107
- David A. Hafler$48,350,086
- Samia J. Khoury$10,360,565
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCombination ChemotherapyCyclophosphamideDrug ResistanceDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationImmunologic Assay /TestImmunotherapyInterferon BetaInterleukin 10Interleukin 12Interleukin 4Intravenous AdministrationMagnetic Resonance ImagingMethylprednisoloneMitoxantroneMultiple SclerosisNervous System Disorder ChemotherapyNeuropsychological TestsNeutralizing AntibodyOutcomes ResearchRelapse /RecurrenceTransforming Growth Factors
Grant awards (4)
PULSE THERAPY TRIAL IN BETA INTERFERON RESISTANT ACTIVE$133,920
K23 · FY2003 · NS
PULSE THERAPY TRIAL IN BETA INTERFERON RESISTANT ACTIVE$133,920
K23 · FY2002 · NS
PULSE THERAPY TRIAL IN BETA INTERFERON RESISTANT ACTIVE$133,920
K23 · FY2001 · NS
PULSE THERAPY TRIAL IN BETA INTERFERON RESISTANT ACTIVE$133,920
K23 · FY2000 · NS